RNAC
Cartesian Therapeutics (RNAC)
$49
About Cartesian Therapeutics (RNAC)
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.
Details
Daily high
$6.65
Daily low
$6.28
Price at open
$6.50
52 Week High
$20.00
52 Week Low
$5.98
Market cap
168.8M
Dividend yield
0.00%
Volume
122,821
Avg. volume
101,832
P/E ratio
-.12
Cartesian Therapeutics News
Details
Daily high
$6.65
Daily low
$6.28
Price at open
$6.50
52 Week High
$20.00
52 Week Low
$5.98
Market cap
168.8M
Dividend yield
0.00%
Volume
122,821
Avg. volume
101,832
P/E ratio
-.12